FDA clears new cloud-enabled Philips cardiovascular IT system
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the latest release of Philips Healthcare's Cardiovascular Workspace imaging and information management system. It enables cloud-hosted availability and software-as-a-Service (SaaS) deployment.
The company said by accessing the cardiovascular information system (CVIS) using the Philips HealthSuite digital cloud platform, health systems can accelerate adoption of artificial intelligence (AI), automate data analysis, documentation, and reporting.
A major trend in healthcare IT systems over the past few years has been a movement to the cloud so hospitals no longer need to maintain large data centers, to enable anytime and anywhere access to patient data and imaging, make software updates easier, and to allow access to AI. The goal is to ease IT management, reduce operational costs, and accelerate AI adoption.
“Our cloud-enabled Cardiovascular Workspace provides the foundation for future AI enabled tools and workflow insights across the cardiology care continuum,” explained Madhuri Sebastian, Philips business leader for imaging informatics in a statement. “With cloud deployment, we are enabling secure remote reading and improving efficiency. Our approach is a true differentiator, because it unlocks the ability to scale and innovate through large datasets."
The company also said its cloud platform helps integrate cardiovascular services to the existing Philips radiology PACS HealthSuite offering to streamline imaging workflows.
The cloud offering is made possible through a collaboration with Amazon Web Services (AWS).
"In cardiovascular care especially, the ability to scale innovation depends on unlocking the power of data through secure, cloud-enabled solutions across the entire care continuum," said Dr. Rowland Illing, chief medical officer and director, healthcare and life sciences at Amazon Web Services. "Philips is building the kind of integrated data ecosystem that empowers clinicians with actionable insights and delivers measurable impact for patients."
